For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Progenity, Inc.

USPTO Granted Patents = 20

% Expired Patents = 15.0

EPO Patents = 13

Trademarks = 2

Forward Citations = 65

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Mitchell Lawrence Jones (10 out of 36 patents)

Sharat Singh (9 out of 100 patents)

Christopher Loren Wahl (6 out of 26 patents)

4. Matthew Sekedat (4 out of 7 patents)

5. Amin R Mazloom (3 out of 15 patents)

6. Mark Sasha Drlik (3 out of 20 patents)

7. Harry Stylli (3 out of 17 patents)

8. Pankaj Oberoi (2 out of 27 patents)

9. Jeffrey A Shimizu (2 out of 7 patents)

10. Jeffrey Buis (2 out of 5 patents)

11. Ronald David Beaubien, Jr (2 out of 7 patents)

12. Jeff Perry (2 out of 5 patents)

13. Jung H Kim (2 out of 2 patents)

14. Heng Wang (2 out of 2 patents)

15. Tobias Mann (2 out of 16 patents)

20 patents: Sort by Forward Citations

1. 12668833 - METHODS, SYSTEMS, AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES (2026-06-30),

2. 11333672 - Preeclampsia biomarkers and related systems and methods (2022-05-17),

3. 11327071 - Assessment of preeclampsia using assays for free and dissociated placental growth factor (2022-05-10),

4. 11241562 - Ingestible device with relatively large payload volume (2022-02-08),

5. 11224364 - Ingestible device and associated methods (2022-01-18),

6. 11186863 - Methods, systems, and compositions for counting nucleic acid molecules (2021-11-30),

7. 11134889 - Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor (2021-10-05),

8. 11112403 - Assessment of preeclampsia using assays for free and dissociated placental growth factor (2021-09-07),

9. 11033490 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2021-06-15),

10. 11007356 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2021-05-18),

11. 10980739 - Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor (2021-04-20),

12. 10947595 - Nucleic acids and methods for detecting chromosomal abnormalities (2021-03-16),

13. 10835152 - Electromechanical pill device with localization capabilities (2020-11-17),

14. 10610104 - Gastrointestinal tract detection methods, devices and systems (2020-04-07),

15. 10588608 - Sampling systems and related materials and methods (2020-03-17),

Company Overview

Progenity, Inc. is a biotechnology company based in San Diego, California, specializing in innovative molecular testing solutions. The organization focuses on developing non-invasive tests that provide critical information for prenatal and gastrointestinal health. Progenity leverages advanced technologies in genomics and diagnostics to enhance patient care and improve clinical outcomes. With a commitment to precision medicine, the company aims to empower healthcare providers and patients with actionable insights derived from genetic data.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#302 in San Diego, CA

#3,937 in California

#16,395 in US

#31,264 in the World

San Diego, CA, United States of America

Progenity, Inc.

Forward Citations = 65

58 inventors:

Mitchell Lawrence Jones (10 out of 36 patents)

Sharat Singh (9 out of 100 patents)

Christopher Loren Wahl (6 out of 26 patents)

4. Matthew Sekedat (4 out of 7 patents)

5. Amin R Mazloom (3 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Progenity, Inc.. Retrieved from https://idiyas.com/company/progenity

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…